SECURITIES NOTICE: Rosen Law Firm Reminds Esperion Therapeutics, Inc. Investors of Important March 14, 2016 Deadline in Class...
March 09 2016 - 7:46PM
Rosen Law Firm, a global investor rights law firm, reminds
purchasers of Esperion Therapeutics, Inc. securities (NASDAQ:ESPR)
from August 18, 2015 through September 28, 2015, both dates
inclusive (the “Class Period”) of the important March 14, 2016 lead
plaintiff deadline in the class action. The lawsuit seeks to
recover damages for Esperion Therapeutics investors under the
federal securities laws.To join the Esperion Therapeutics class
action, go to the firm’s website at
http://rosenlegal.com/cases-814.html or call Phillip Kim, Esq. or
Kevin Chan, Esq. toll-free at 866-767-3653 or email
pkim@rosenlegal.com or kchan@rosenlegal.com for information on the
class action. NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION.
UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL
UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER
AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR
CHOICE.According to the lawsuit, throughout the Class Period,
Defendants issued materially false and misleading statements to
investors and/or failed to disclose that there was no clear path to
approval for ETC-1002, the FDA had encouraged Esperion Therapeutics
to initiate a cardiovascular outcomes trial (“CVOT”) and completion
of a CVOT could be necessary prior to approval of ETC-1002. When
the true details entered the market, the lawsuit claims that
investors suffered damages.A class action lawsuit has already been
filed. If you wish to serve as lead plaintiff, you must move the
Court no later than March 14, 2016. A lead plaintiff is a
representative party acting on behalf of other class members in
directing the litigation. If you wish to join the litigation, go to
the firm’s website at http://rosenlegal.com/cases-814.html or to
discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law
Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com
or kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the
globe, concentrating its practice in securities class actions and
shareholder derivative litigation. Attorney Advertising. Prior
results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024